Back to GetFilings.com



Table of Contents

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly Period Ended June 30, 2004

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Transition Period From                  to                 

 

Commission File Number 000-49871

 

 

HEALTHETECH, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   77-0478611
(State or other jurisdiction of incorporation or organization)   (I.R.S. employer identification no.)

523 Park Point Drive, 3rd Floor,

Golden, Colorado

  80401
(Address of principal executive office)   (Zip code)

 

Registrant’s telephone number, including area code: (303) 526-5085

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No   x

 

As of August 6, 2004, the number of shares outstanding of the registrant’s common stock, par value $0.001 per share, 7,086,215.

 



Table of Contents

INDEX

 

          Page

PART I.    FINANCIAL INFORMATION    1
Item 1.    Unaudited Financial Statements    1
     Unaudited Balance Sheets    1
     Unaudited Statements of Operations    2
     Unaudited Statements of Cash Flows    3
     Notes to Unaudited Financial Statements    4
Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations    9
Item 3.    Quantitative and Qualitative Disclosures About Market Risk    15
Item 4.    Controls and Procedures    15
PART II.    OTHER INFORMATION    15
Item 1.    Legal Proceedings    15
Item 2.    Changes in Securities and Use of Proceeds    15
Item 3.    Defaults Upon Senior Securities    16
Item 4.    Submission of Matters to a Vote of Security Holders    16
Item 5.    Other Information    16
Item 6.    Exhibits and Reports on Form 8-K    17
SIGNATURES    18
EXHIBIT INDEX    19

 


Table of Contents

PART I. FINANCIAL INFORMATION

 

ITEM 1. Unaudited Financial Statements

 

HEALTHETECH, INC.

Balance Sheets

 

    

December 31,

2003


   

June 30,

2004


 
           (unaudited)  

ASSETS

              

Current assets:

              

Cash and cash equivalents

   $ 17,003,224     12,762,288  

Receivables, net of allowance of $307,000 and $307,000 respectively

     620,428     555,839  

Inventory

     1,908,233     1,708,272  

Prepaid expenses

     676,360     305,681  

Other current assets

     17,979     54,560  
    


 

Total current assets

     20,226,224     15,386,640  

Property and equipment, net

     1,843,841     1,332,355  

Deposits

     266,398     265,313  

Intangible assets, net of accumulated amortization of $2,796,970 and $2,895,988 in 2003 and 2004, respectively

     1,555,742     1,498,633  
    


 

TOTAL ASSETS

   $ 23,892,205     18,482,941  
    


 

LIABILITIES & STOCKHOLDERS’ EQUITY

              

Current liabilities:

              

Accounts payable

   $ 567,479     326,875  

Accrued liabilities

     1,052,133     618,157  

Deferred revenue

     71,657     65,183  
    


 

Total current liabilities

     1,691,269     1,010,215  

Other liabilities

     171,640     93,250  
    


 

Total liabilities

     1,862,909     1,103,465  

Stockholders’ equity:

              

Common stock, $0.001 par value, 100,000,000 shares authorized; 7,041,954 and 7,086,215 shares issued and outstanding in 2003 and 2004, respectively

     7,042     7,086  

Deferred stock-based charges

     (1,817,371 )   (1,676,731 )

Additional paid-in capital

     114,764,010     115,552,559  

Accumulated deficit

     (90,924,385 )   (96,503,438 )
    


 

Total stockholders’ equity

     22,029,296     17,379,476  
    


 

Commitments and contingencies

              

TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY

   $ 23,892,205     18,482,941  
    


 

 

 

The accompanying notes are an integral part of these unaudited financial statements.

 

1


Table of Contents

HEALTHETECH, INC.

Statements of Operations

Unaudited

 

     Three Months Ended June 30,

    Six Months Ended June 30,

 
     2003

    2004

    2003

    2004

 

Revenue:

                                

Product and measurement sales

   $ 675,235     $ 791,079     $ 1,603,353     $ 1,403,042  

Software and other

     533,185       249,676       1,223,123       376,960  
    


 


 


 


Total revenue

     1,208,420       1,040,755       2,826,476       1,780,002  
    


 


 


 


Cost of revenue:

                                

Product and measurement sales

     677,370       669,915       1,549,084       1,132,116  

Software and other

     459,895       132,433       733,415       307,536  

Stock-based charges

     2,631       7,257       51,146       25,037  
    


 


 


 


Total cost of revenue

     1,139,896       809,605       2,333,645       1,464,689  
    


 


 


 


Gross profit

     68,524       231,150       492,830       315,314  

Operating expenses:

                                

Research and development, excluding $101,295, $112,668, $680,740, and $295,492 of stock-based charges for the three months ended June 30, 2003 and 2004 and the six months ended June 30, 2003 and 2004, respectively

     1,681,133       718,297       4,115,953       1,503,829  

Selling, general and administrative, excluding $390,109, $202,487 $1,279,010, and $520,320 of stock-based charges for the three months ended June 30, 2003 and 2004 and the six months ended June 30, 2003 and 2004, respectively

     2,843,581       1,689,695       10,333,790       3,277,586  

Restructuring charges and asset impairment

     2,114,026       105,102       2,114,026       377,159  

Stock-based charges

     491,404       315,155       1,959,750       815,812  
    


 


 


 


Total operating expenses

     7,130,144       2,828,248       18,523,520       5,974,386  
    


 


 


 


Loss from operations

     (7,061,620 )     (2,597,099 )     (18,030,690 )     (5,659,073 )

Interest income

     51,115       36,698       124,169       80,842  

Interest expense

     (1,575 )     (120 )     (3,466 )     (822 )
    


 


 


 


Net loss

   $ (7,012,080 )   $ (2,560,520 )   $ (17,909,986 )   $ (5,579,053 )
    


 


 


 


Basic and diluted loss per common share:

   $ (1.79 )   $ (.36 )   $ (4.57 )   $ (.79 )
    


 


 


 


Basic and diluted weighted average number of shares outstanding

     3,923,058       7,082,744       3,920,341       7,073,066  

 

 

The accompanying notes are an integral part of these unaudited financial statements.

 

2


Table of Contents

HEALTHETECH, INC.

Statements of Cash Flows

Unaudited

 

     Six months ended

 
     June 30, 2003

    June 30, 2004

 

Cash flows from operating activities:

                

Net loss

   $ (17,909,986 )   $ (5,579,053 )

Adjustments to reconcile net loss to net cash used in operating activities:

                

Depreciation and amortization

     1,097,325       672,922  

Intangible asset impairment

     1,584,600       —    

Inventory reserves and write-offs

     294,072       846  

Loss on disposal of property and equipment

     —         73,545  

Stock-based charges

     2,010,897       840,849  

Provision for doubtful accounts

     65,000       —    

Change in assets and liabilities:

                

Receivables

     2,329,027       64,589  

Inventory

     (139,105 )     199,115  

Prepaid expenses and other current assets

     2,724,198       334,098  

Deposits

     1,050       1,085  

Accounts payable

     (1,337,676 )     (240,604 )

Accrued and other liabilities

     (39,236 )     (512,366 )

Deferred revenue

     (319,693 )     (6,474 )
    


 


Net cash used in operating activities

     (9,639,527 )     (4,151,447 )
    


 


Cash flows from investing activities:

                

Purchase of property and equipment

     (307,019 )     (135,962 )

Proceeds from the sale of marketable securities

     3,836,711       —    

Purchase of intangible assets

     (166,225 )     (41,909 )

Net change in restricted cash

     (252 )     —    
    


 


Net cash provided by (used in) investing activities

     3,363,215       (177,872 )
    


 


Cash flows from financing activities:

                

Payments on note payable to related party

     (10,000 )     —    

Common stock issuance costs

     —         (22,865 )

Proceeds from common stock option exercises

     106,135       111,248  
    


 


Net cash provided by financing activities

     96,135       88,383  
    


 


Net decrease in cash and cash equivalents

     (6,180,177 )     (4,240,936 )

Cash and cash equivalents, beginning of period

     16,878,263       17,003,224  
    


 


Cash and cash equivalents, end of period

   $ 10,698,086     $ 12,762,288  
    


 


 

 

The accompanying notes are an integral part of these unaudited financial statements.

 

3


Table of Contents

HEALTHETECH, INC.

UNAUDITED NOTES TO FINANCIAL STATEMENTS

 

(1) Business and Basis of Financial Statement Presentation

 

HealtheTech, Inc. (the Company or HealtheTech) was incorporated in February 1998 under the laws of the State of Delaware. The Company operates in one segment and develops and markets health solutions designed to give consumers simple, informative ways to improve and maintain health and wellness.

 

The accompanying financial statements as of June 30, 2004 and for the three months and six months ended June 30, 2003 and 2004 are unaudited and have been prepared in accordance with generally accepted accounting principles on a basis consistent with the December 31, 2003 audited financial statements and include normal recurring adjustments which are, in the opinion of management, necessary for a fair statement of the results of these periods. These statements should be read in conjunction with our financial statements and notes thereto included in our Form 10-K (Commission File No. 000-49871), filed on March 29, 2004. Operating results for the three months and six months ended June 30, 2004 are not necessarily indicative of the results that may be expected for the full year.

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ significantly from those estimates.

 

The Company’s financial statements are based on several significant estimates, including the reserve for warranty obligations and product returns, provision for excess and obsolete inventory, provision for doubtful accounts and the estimated useful lives of long-lived assets, as well as the recoverability of the investment in long-lived assets.

 

(2) Significant Accounting Policies

 

(a) Cash and Cash Equivalents and Restricted Cash

 

All highly liquid investments purchased with original maturities of three months or less are considered to be cash equivalents.

 

(b) Reclassifications

 

Certain reclassifications have been made to prior period financial statements to conform to the 2004 presentation.

 

(c) Inventory

 

Inventory is stated at the lower of cost or market, using the first-in, first-out method and consists of purchased items or finished goods that were manufactured internally or for the Company by contract manufacturers. Our strategy utilizes both in-house and outsourced manufacturing, warehousing and shipping of our health monitoring devices, disposables and software to benefit from the resources of our contract manufacturers and fulfillment vendor where appropriate, in order to minimize the overall costs of our products. We rely on contractors for the manufacture, warehousing and shipping of the component parts for our devices.

 

(d) Intangible Assets

 

Intangible assets consist of purchased patents and legal fees to obtain patents and are recorded at cost. Amortization of intangible assets is calculated using the straight-line method over the estimated useful lives, generally five to ten years. Amortization expense was $132,244 and $50,074 for the three months ending June 30, 2003 and 2004, respectively and $276,490 and $99,018 for the six months ending June 30, 2003 and 2004, respectively. The Company periodically evaluates the recoverability of intangible assets and takes into account events and circumstances that warrant revised estimates of useful lives or that indicate that impairment exists.

 

(e) Accrued liabilities

 

Accrued liabilities consist of the following:

 

     December 31,
2003


   June 30,
2004


          (unaudited)

Customer deposit

   $ 123,842